International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8095 - 8095
Published: July 25, 2024
Elevated
levels
of
homocysteine
(Hcy)
and
related
metabolites
are
associated
with
Alzheimer's
disease
(AD).
Severe
hyperhomocysteinemia
causes
neurological
deficits
worsens
behavioral
biochemical
traits
AD.
Although
Hcy
is
precluded
from
entering
the
Genetic
Code
by
proofreading
mechanisms
aminoacyl-tRNA
synthetases,
thus
a
non-protein
amino
acid,
it
can
be
attached
to
proteins
via
an
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 1290 - 1290
Published: Jan. 20, 2024
Despite
significant
therapeutic
advancements,
morbidity
and
mortality
following
myocardial
infarction
(MI)
remain
unacceptably
high.
This
clinical
challenge
is
primarily
attributed
to
two
factors:
delayed
reperfusion
the
injury
resulting
from
coronary
reperfusion.
Following
reperfusion,
there
a
rapid
intracellular
pH
shift,
disruption
of
ionic
balance,
heightened
oxidative
stress,
increased
activity
proteolytic
enzymes,
initiation
inflammatory
responses,
activation
several
cell
death
pathways,
encompassing
apoptosis,
necroptosis,
pyroptosis.
The
or
pyroptosis
encompasses
multiprotein
complex
known
as
NLRP3
inflammasome.
High-density
lipoproteins
(HDL)
are
endogenous
particles
whose
components
can
either
promote
mitigate
In
this
comprehensive
review,
we
explore
role
inflammasome
in
context
MI
provide
detailed
analysis
how
HDL
modulate
process.
Nutraceuticals,
Journal Year:
2024,
Volume and Issue:
4(4), P. 469 - 502
Published: Sept. 30, 2024
High-density
lipoprotein
(HDL)
has
been
proposed
to
provide
cardio-protective
properties
through
the
functionality
of
its
anti-inflammatory
and
antioxidant
enzymatic
machinery.
Within
this
article,
beneficial
effects
several
functional
foods
on
HDL
levels
for
cardio-protection
are
thoroughly
reviewed.
Emphasis
is
given
their
health-promoting
cardiovascular
system
benefits
HDL,
which
act
either
solely
or
synergistically
as
an
adjuvant
approach
with
well-established
anti-atherogenic
therapies.
Promising
outcomes
from
both
in
vitro
vivo
studies
animal
models
clinical
trials,
outline
such
functionality,
discussed.
The
mechanisms
obtained
antioxidant,
anti-inflammatory,
antithrombotic,
activities
containing
natural
bioactives
also
outlined.
Limitations
future
perspectives
overall
that
these
bioactive
compounds
exert
important
ingredients
induce
HDL-related
strengthen
health
Clinics and Practice,
Journal Year:
2025,
Volume and Issue:
15(5), P. 86 - 86
Published: April 25, 2025
Background:
Heart
failure
(HF)
is
a
leading
cause
of
mortality
across
the
globe,
prompting
ongoing
research
into
novel
biomarkers
for
improved
risk
stratification
and
patient
management.
Methods:
This
cross-sectional
study
aimed
to
investigate
relationship
between
two
promising
biomarkers,
tetranectin
paraoxonase
1,
severity
heart
in
cohort
87
patients
with
cardiovascular
factors.
Participants
were
categorized
three
groups
based
on
their
New
York
Association
(NYHA)
classification:
no
HF
(Control),
NYHA
class
I
(G1),
II-IV
(G2).
Results:
Our
analysis
revealed
stepwise
decrease
both
TETRA
PON1
levels
increasing
severity,
Control
group
exhibiting
highest
G2
lowest.
Interestingly,
significant
positive
correlation
was
observed
only
group,
suggesting
potential
interplay
these
healthy
individuals
that
may
be
disrupted
onset
HF.
Furthermore,
positively
associated
left
ventricular
ejection
fraction
(LVEF)
negatively
diastolic
dysfunction,
indicating
involvement
systolic
cardiac
function.
Conclusions:
These
findings
suggest
serve
as
valuable
assessing
prognosis.
Further
warranted
validate
larger,
prospective
studies
explore
clinical
utility
guiding
treatment
decisions.
Future Journal of Pharmaceutical Sciences,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: May 6, 2025
Abstract
Background
Primary
percutaneous
coronary
intervention
(PPCI)
is
the
treatment
of
choice
for
ST-segment-elevation
myocardial
infarction
(STEMI).
Post-PCI
induced-oxidative
stress,
a
complication
PCI,
linked
to
no-reflow
(NR)
phenomenon
and
poor
prognosis.
A
clinical
trial
involving
70
STEMI
patients
was
conducted
evaluate
impact
alpha
lipoic
acid
(ALA),
an
antioxidant
anti-inflammatory
agent,
on
oxidative
stress
NR.
The
participants
were
randomized
standard
care
(control
group)
or
600
mg
IV
infusion
ALA
pre/peri
PPCI
then
orally
once
28
days
plus
(ALA
group).
Outcomes
included
degree
reperfusion
by
thrombolysis
in
(TIMI)
flow
blush
grade
(MBG),
Aldehyde
dehydrogenase
2
(ALDH2)
Paroxonase
1
(PON-1)
levels,
also
left
ventricular
ejection
fraction
(LVEF),
major
adverse
cardiac
events
(MACE).
Results
TIMI
grade-3
MBG
significantly
higher
group
versus
controls
(97.1%
62.9%,
respectively,
P
=
0.001,
82.9%,
45.7%,
0.002).
ALDH2
PON-1
levels
post-PPCI
at
all-time
points
(24
h
7
days).
exhibited
better
LVEF
when
compared
controls.
Conclusion
supplementation
decreased
occurrence
NR,
reduced
ischemia–reperfusion
injury
(IRI)
post-PPCI,
increased
ALDH2,
improved
LVEF.
Journal of Immunology Research,
Journal Year:
2003,
Volume and Issue:
10(2-4), P. 203 - 211
Published: Jan. 1, 2003
We
recently
reported
[J.
Lipid
Res.
42
(2001),
697;
43
(2002),
1486;
44
(2003),
716]
that
[beta2-glycoprotein
I
(beta2GPI)
forms
complexes
with
oxidized
LDL
(oxLDL)
and
autoantibodies
against
these
are
present
in
patients
SLE
antiphospholipid
syndrome
(APS).
The
relationship
of
beta2GPI/oxLDL
IgG
beta2GPI
complexed
oxLig-1
(an
oxLDL-derived
ligand)
clinical
manifestations
APS
was
studied
150
patients.
levels
were
similar
to
those
without
APS,
but
they
significantly
higher
than
healthy
individuals.
There
no
difference
the
complex
among
arterial,
venous
thrombosis,
or
pregnancy
morbidity.
anti-beta2GPI/oxLig-1
Further,
antibody
arterial
thrombosis
Thus,
oxidation
leads
formation
In
contrast,
generated
only
strongly
associated
thrombosis.
These
results
suggest
etiologically
important
development
atherosclerosis
APS.
Open Life Sciences,
Journal Year:
2010,
Volume and Issue:
6(1), P. 32 - 40
Published: Nov. 15, 2010
Abstract
Reducing
postprandial
oxidative
stress
(OxS),
decreasing
blood
triglyceride
level
(TG)
and
improving
lipoprotein
status
is
likely
to
have
a
preventive
impact
on
the
development
of
cardiovascular
disease
(CVD).
Previously
we
shown
that
antioxidant
probiotic
Lactobacillus
fermentum
ME-3
(DSM14241)
characterized
by
antiatherogenic
effects.
This
randomized
double-blind
placebo-controlled
study
evaluated
influence
kefir
enriched
with
an
antioxidative
L.
(LfKef)
OxS,
TG
response
status.
100
clinically
healthy
subjects
were
recruited
into
study.
Blood
parameters
determined
oxidized
LDL,
baseline
diene
conjugation
in
LDL
(BDC-LDL),
complex
beta-2
glycoprotein
(Beta2-GPI-oxLDL),
paraoxonase
(PON)
activity,
LDL-Chol,
HDL-Chol
TG.
To
evaluate
general
body
OxS-load
measured
8-isoprostanes
(8-EPI)
urine.
Consumption
LfKef
significantly
reduced
BDC-LDL,
Beta2-GPI-oxLDL,
urinary
caused
significant
increase
PON
activity.
first
evidence
may
positive
effect
both
OxS
as
well
Renal Failure,
Journal Year:
2024,
Volume and Issue:
46(2)
Published: July 10, 2024
Paraoxonase
1
(PON1)
is
one
of
the
most
significant
antioxidative
enzymes
associated
with
high-density
lipoprotein
(HDL).
It
has
been
proved
that
involved
in
pathogenesis
many
diseases
including
chronic
kidney
disease
(CKD).
The
association
between
PON1
and
CKD
seems
to
be
mutual,
such
produces
a
decrease
activity
levels,
while
genetics
may
affect
risk
susceptibility
CKD.
Recent
studies
reveal
serum
observed
non-dialyzed
dialyzed
patients
as
well
renal
transplant
(RT)
linked
an
increased
vulnerability
atherosclerosis.
We
intend
summarize
current
literature
concerning
CKD,
highlighting
on
main
determinants
activity,
its
oxidative
stress,
impact
genetic
polymorphism
development,
effect
drugs
nutritional
state.
Furthermore,
evidence
supporting
implication
reduced
incident
cardiovascular
patients,
also
examined.
appears
despite
lack
standardization
measurement,
remains
valuable
biomarker
for
researchers
through
last
decades,
which
contributes
assessment
antioxidant
status
having
prognostic
benefit
adverse
clinical
outcomes
at
various
stages
etiologies
disease.